The UK health authorities on Saturday approved a second bivalent vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19. The Medicines and Healthcare produ...

Microbiologist Soumitra Das and his team along with collaborators at IISc, have developed and tested a novel virus-like particle (VLP) - a non-infectious nanoscale molecule that resembles and beh...

Vaccinated people who were infected by the first Omicron subvariants have four times greater protection than jabbed people who did not catch the COVID-19 infection, according to a study. The research...

The European Medicines Agency has given its authorization for the use of vaccines against the omicron variant of COVID-19 to both Moderna and BioNTech-Pfizer. The EU's drug regulator, the Europea...

India’s first-quarter double-digit growth figure looks great -- but looks can be deceiving.  At one level, we can say that we're the world’s fastest-growing economy. At another, ...

Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, reports ndtv.com on Monday. SII, the world&...

The UK health authorities announced on Monday that the country has become the first to approve a so-called bivalent Covid vaccine that targets both the original strain of Covid-19 and the Omicron vari...

China raced on Tuesday to stamp out Covid-19 outbreaks in the tourist hubs of Tibet and Hainan, with the authorities launching more rounds of mass testing and closing venues to contain the highly tran...

People who've had Omicron could have a high level of protection against the BA.4 and BA.5 variants that are now sweeping the globe.  A detailed study carried out in Qatar shows between May 7...

The coronavirus SARS-CoV-2 is quite versatile, with a large number of variants and subvariants. The omicron variant alone has more than 130 sublineages. In Europe, the omicron subvaria...